Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-30 5:28 pm Unchanged | 2025-01-28 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 209,640 10.000% | 0 (Unchanged) | Filing History |
| 2025-01-30 5:27 pm Unchanged | 2025-01-28 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 10.100% | 0 (Unchanged) | Filing History |
| 2025-01-23 6:11 pm Purchase | 2025-01-21 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 209,640 11.500% | 209,640 (New Position) | Filing History |
| 2025-01-23 6:08 pm Unchanged | 2025-01-21 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 11.700% | 0 (Unchanged) | Filing History |
| 2025-01-17 8:17 pm Unchanged | 2025-01-15 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 16.200% | 0 (Unchanged) | Filing History |
| 2025-01-03 9:25 pm Unchanged | 2024-12-31 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 16.200% | 0 (Unchanged) | Filing History |
| 2025-01-03 3:54 pm Sale | 2024-12-31 | 13G | Lipella Pharmaceuticals Inc. LIPO | SABBY MANAGEMENT LLC | 60,325 4.900% | -12,152 (-16.77%) | Filing History |
| 2024-12-27 9:31 pm Purchase | 2024-12-23 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 16.200% | 212,289 (New Position) | Filing History |
| 2024-11-14 5:09 pm Purchase | 2024-09-30 | 13G | Lipella Pharmaceuticals Inc. LIPO | Gruber Michele | 46,875 3.900% | 46,875 (New Position) | Filing History |
| 2024-11-14 5:00 pm Purchase | 2024-09-30 | 13G | Lipella Pharmaceuticals Inc. LIPO | Huang Leaf | 69,443 5.700% | 69,443 (New Position) | Filing History |
| 2024-10-17 5:00 pm Purchase | 2024-10-15 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,294 16.200% | 11,250 (+5.60%) | Filing History |
| 2024-10-17 5:00 pm Unchanged | 2024-10-15 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 209,642 16.000% | 0 (Unchanged) | Filing History |
| 2024-08-19 4:05 pm Purchase | 2024-08-16 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 209,642 18.800% | 16,667 (+8.64%) | Filing History |
| 2024-05-06 4:05 pm Sale | 2024-05-02 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 201,044 19.300% | -3,333 (-1.63%) | Filing History |
| 2024-03-19 4:10 pm Purchase | 2024-03-15 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 204,377 21.000% | 16,875 (+9.00%) | Filing History |
| 2024-03-15 12:15 pm Purchase | 2024-03-13 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 192,975 20.000% | 18,113 (+10.36%) | Filing History |
| 2024-03-15 12:13 pm Purchase | 2024-03-13 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 187,502 19.500% | 18,113 (+10.69%) | Filing History |
| 2024-03-06 5:05 pm Purchase | 2024-03-04 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 169,389 18.300% | 10,833 (+6.83%) | Filing History |
| 2024-03-06 5:03 pm Purchase | 2024-03-04 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 174,862 18.900% | 10,833 (+6.60%) | Filing History |
| 2024-02-07 5:29 pm Purchase | 2023-12-31 | 13G | Lipella Pharmaceuticals Inc. LIPO | Gruber Michele | 45,625 5.500% | 1,458 (+3.30%) | Filing History |